Who owns TRAX?
Institutional ownership of First Tracks Biotherapeutics Inc. from Form 13F, Q2 2026
149 institutional managers reported holding First Tracks Biotherapeutics Inc. (TRAX) in Form 13F filings for Q2 2026, with 32,861,600 shares worth $661M. The largest reported holder was EcoR1 Capital, LLC. 147 opened new positions and 0 sold out.
- Funds holding
- 149
- Value held
- $661M
- New / sold out
- 147 / 0
- Net shares, same filers
- None
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of TRAX
Share of 13F holdings is each fund's shares as a share of the 32,861,600 TRAX shares all 13F filers reported, not of shares outstanding.
Questions about TRAX ownership
- Who owns TRAX stock?
- 149 institutional investment managers reported TRAX positions in their Form 13F filings for Q2 2026, holding 32,861,600 shares worth $661M in total. EcoR1 Capital, LLC reported the largest position.
- Are funds buying or selling TRAX?
- 147 managers opened new TRAX positions in Q2 2026.
- How current is this TRAX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to TRAX by CUSIP. Options are left out. TRAX news and filings · TRAX insider trades · Top funds